Publications by authors named "Vanessa M K Pazdernik"
Article Synopsis
- New immunoglobulin free light chain (FLC) assays, including FreeLite and Sebia, can be used interchangeably for diagnosing multiple myeloma and assessing risk in patients with MGUS, despite differing methodologies.
- A study of 923 MGUS patients showed that both assays had comparable effectiveness in predicting progression to plasma cell dyscrasias (PCD) over a median follow-up of 38 years.
- The Sebia assay offered improved risk stratification with a lower clinical decision point for patients with low FLC ratios, demonstrating the potential for its application alongside traditional models.
